Michael Ramirez, Ph.D.

Oncology Consultant @ Kantar Health. Views expressed are my own.

[NBC News @NBCNews]

LIVE: @NBCNews special coverage ahead of tonight's second and final presidential debate between President Trump and Joe Biden. #Debates2020 https://t.co/Fy6oEDLcuQ

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Investigator mPFS:

Opdivo/Cabometyx - 19.4 months
Sutent - 9.2 months

Investigator ORR:

Opdivo/Cabometyx - 59.4%
Sutent - 32.0%

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Check out this vlog I did on the results for CheckMate-9ER! These results have the potential to deepen the competition in 1L RCC and further transform SOC. #ESMO2020 #VirtualESMO #CM9ER #CheckMate9ER #RCC #Oncology

https://t.co/YISzkkchvn

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Late breaking abstracts for #ASCO20 released! Excited to see the presentation for ADAURA on Sunday, as the debate on whether OS is needed to change practice continues!

[John D Carroll @JohnCendpts]

AstraZeneca trumpets the good data they found for Tagrisso in an adjuvant setting for NSCLC — but many of the experts aren’t cheering along
https://t.co/GZgwTbDU3g

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

@Miljenkoz Not surprised that it was approved, but that it was approved so early

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Well here's a surprise...#Opdivo + ipi + limited chemo approved early for 1L NSCLC based on #CM9LA...ahead of #ASCO20 presentation and manuscript publication

[Dr. Antonio Calles 🫁🚭 @Tony_Calles]

CM-9LA approved by @US_FDA before data presentation at #ASCO20 or manuscript publication #LCSM #OncoAlert
https://t.co/Dw679mCcno

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

@ScripMandy Griffen Park! Is that little trail area next to the park still open?

[Zachary McLellan @biotechzm]

https://t.co/n0wSpkmgOQ

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

As well as the site for Informa Pharma Intelligence @Pharma_Intell, which also contains collated info on our #COVID19 coverage:

https://t.co/XhhYwY082w

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Additional episodes of the vlog series on #COVID19 from @danpharma can be found on the #YouTube channel of Informa Pharma Intelligence, @Pharma_Intell:

https://t.co/hQA2b5y15r

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Additional episodes of the vlog series on #COVID19 from @danpharma can be found on the #YouTube channel of Informa Pharma Intelligence, @Pharma_Intell:

https://t.co/hQA2b5y15r

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Excellent daily vlog series on #YouTube by Director of Thought Leadership at Informa Pharma @danpharma, where Dan talks about verified info on #COVID19, with a focus on drug development efforts:

1st episode: https://t.co/4K6lBsJnCV

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Excellent daily vlog series on #YouTube by Director of Thought Leadership at Informa Pharma @danpharma, where Dan talks about verified info on #COVID19, with a focus on drug development efforts:

1st episode: https://t.co/4K6lBsJnCV

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

Check out the new episode of the Informa Pharma Intelligence Podcast, where Derek Burkhard, Head of Financial Content, discusses the pharma earnings season, spinoffs, M&A, and the potential impact of #COVID19 on the industry: https://t.co/CgT4Vu2Q6J

[Pink Sheet @PharmaPinkSheet]

Expanded Lung Cancer Claim For Lilly’s Cyramza Faces US FDA Scrutiny
https://t.co/eauBlFrLrX #PinkSheet

[Pink Sheet @PharmaPinkSheet]

EU & US At Odds Over Merck’s Keytruda
https://t.co/uDVVT6M8UN #PinkSheet

[Mandy Jackson @ScripMandy]

$GILD CAR-T Yescarta sales flattening out.

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

First episode of the year for the Informa Pharma Intelligence Podcast, covering #JPM20. Listen in as @Jessicaemerrill and @awmcconaghie share their key takeaways from the meeting:

https://t.co/EvnJt8lkV0

[Mandy Jackson @ScripMandy]

What a week it’s been - and it’s only Thursday! Here’s our (free) #JPM20 Day 3 roundup. One more Notebook to come & many stories to follow over the coming weeks from insightful interviews @PharmaScrip & @PharmaPinkSheet did on the ground in San Francisco. https://t.co/jAD3qpyFe7

[Mandy Jackson @ScripMandy]

It’s Day 3 of #JPM20 and here’s our Day 2 roundup, free for your reading pleasure. $GSK $PFE $AMGN $LLY $KPTI $AZN https://t.co/NZCnWrHWgn

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

For all those heading out to #ASH19 this year, check out the Informa Pharma Intelligence Podcast (free) where we preview some abstracts that caught our eye!

https://t.co/etDqf940tj

[Michael Ramirez, Ph.D. @pharma_MR_PhD]

New Informa Pharma Intelligence Podcast episode:

https://t.co/IVoI1V5PUG

@Datamonitor_PS Pamela Spicer talks aducanumab moving from futility to FDA filing for Alzheimer's disease

@amandamicklus Amanda Micklus does a cell/gene therapy news round-up

#aducanumab #genetherapy